Cancers | Free Full-Text | The Diagnostic Value of the CA19-9 and Bilirubin Ratio in Patients with Pancreatic Cancer, Distal Bile Duct Cancer and Benign Periampullary Diseases, a Novel Approach
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports
![PDF] Reference values and biological variation for tumor marker CA 19-9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in a Caucasian population. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bb127959fd840127d322eb4c0f3133e4069e5c6a/4-Table4-1.png "PDF] Reference values and biological variation for tumor marker CA 19-9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in a Caucasian population. | Semantic Scholar")
PDF] Reference values and biological variation for tumor marker CA 19-9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in a Caucasian population. | Semantic Scholar
Cholangiocarcinoma
JCM | Free Full-Text | Prognostic Impact of Perioperative CA19-9 Levels in Patients with Resected Perihilar Cholangiocarcinoma
Univariate analysis of CA 19-9 and CEA as a categorical variable | Download Table
PDF) CA 19?9 and CE A are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis | Einar Björnsson - Academia.edu
Biliary Tract Cancers | NEJM
![PDF] Reference values and biological variation for tumor marker CA 19-9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in a Caucasian population. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bb127959fd840127d322eb4c0f3133e4069e5c6a/2-Figure1-1.png "PDF] Reference values and biological variation for tumor marker CA 19-9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in a Caucasian population. | Semantic Scholar")
PDF] Reference values and biological variation for tumor marker CA 19-9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in a Caucasian population. | Semantic Scholar
Cancers | Free Full-Text | Treatment of Intrahepatic Cholangiocarcinoma—A Multidisciplinary Approach
Cholangiocarcinoma - Wikipedia
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology
Cholangiocarcinoma | Nature Reviews Disease Primers
Antibodies to a CA 19-9 Related Antigen Complex Identify SOX9 Expressing Progenitor Cells In Human Foetal Pancreas and Pancreatic Adenocarcinoma | Scientific Reports
Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas – A retrospective tumor marker prognostic study - ScienceDirect
The Highest Ever Reported Level of Carbohydrate Antigen 19-9: A Case Report | Al-Khallaf | Journal of Medical Cases
Abbreviations: ICC, intrahepatic cholangiocarcinoma; BTC, biliary tract... | Download Scientific Diagram
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports
![PDF] State of serum markers for detection of cholangiocarcinoma. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c14d81ca234c0d592f2e72050604bd015d1da96f/3-Table3-1.png "PDF] State of serum markers for detection of cholangiocarcinoma. | Semantic Scholar")
PDF] State of serum markers for detection of cholangiocarcinoma. | Semantic Scholar
Genotyping of circulating tumor DNA in cholangiocarcinoma reveals diagnostic and prognostic information | Scientific Reports
Frontiers | Tumor Burden Score Stratifies Prognosis of Patients With Intrahepatic Cholangiocarcinoma After Hepatic Resection: A Retrospective, Multi-Institutional Study
Frontiers | Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology
Relationship Between CA 19.9 and the Lewis Phenotype: Options to Improve Diagnostic Efficiency | Anticancer Research
